rs1060503666
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_000268.4(NF2):c.676-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000268.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF2 | NM_000268.4 | c.676-2A>G | splice_acceptor_variant, intron_variant | Intron 7 of 15 | ENST00000338641.10 | NP_000259.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Neurofibromatosis, type 2 Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in NF2 are known to be pathogenic. This particular variant has been reported in the literature  in a patient with three non-vestibular schwannomas, consistent with neurofibromatosis type 2 (NF2) (PMID: 21906157). It has also been seen in an individual with classic NF2 symptoms (Invitae database). This sequence change affects an acceptor splice site in intron 7 of the NF2 gene. It is expected to disrupt mRNA splicing and likely results in an absent or disrupted protein product. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at